Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1991; 18:101-111
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hicks, R.
Right arrow Articles by Schwaiger, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hicks, R.
Right arrow Articles by Schwaiger, M

Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography

RJ Hicks, WH Herman, V Kalff, E Molina, ER Wolfe, G Hutchins, and M Schwaiger

Department of Internal Medicine, University of Michigan Hospitals, Ann Arbor 48109-0028.

Meaning interpretation of metabolic images obtained by positron emission tomography for evaluation of cardiac disease requires a knowledge of the normal variation in regional myocardial substrate metabolism. Recent studies with fluorine-18 (F-18) fluorodeoxyglucose suggest inhomogeneity of myocardial glucose metabolism in the normal human heart, which may relate to substrate availability. Therefore, quantitative evaluation of myocardial oxidative metabolism and glucose metabolism, as derived by dynamic positron emission tomography with carbon-11 (C-11) acetate and F-18 fluorodeoxyglucose, was performed in nine healthy male volunteers. All were studied under tightly controlled metabolic conditions of hyperinsulinemic-euglycemic clamping with and without a concurrent lipid emulsion infusion. Significant inhomogeneity of regional glucose metabolism was noted although it was less than that described under fasting conditions. Glucose utilization was 13% lower in the septum compared with the lateral wall both without and with lipid infusion (0.34 vs. 0.39 mumol/g per min, respectively, p less than 0.05; and 0.33 vs. 0.38 mumol/g per min, respectively, (p less than 0.05). Relatively decreased septal glucose utilization could not be explained by decreased metabolic demand because C-11 clearance constants were marginally higher in the septum than in the lateral wall in both studies (0.055 vs. 0.054 per min, respectively, p = NS; and 0.061 vs. 0.056 per min, respectively, p less than 0.05). Relatively decreased septal glucose utilization could reflect regional variation in substrate use and possible preferential free fatty acid utilization by the septum. These data provide a useful framework for assessing altered cardiac metabolism in disease and support standardization of metabolic conditions during metabolic imaging with positron emission tomography.


This article has been cited by other articles:


Home page
JNMHome page
N. Ohte, K. Kurokawa, A. Iida, H. Narita, S. Akita, K. Yajima, H. Miyabe, J. Hayano, and G. Kimura
Myocardial Oxidative Metabolism in Remote Normal Regions in the Left Ventricles with Remodeling After Myocardial Infarction: Effect of {beta}-Adrenoceptor Blockers
J. Nucl. Med., June 1, 2002; 43(6): 780 - 785.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. P. van der Weerdt, L. J. Klein, R. Boellaard, C. A. Visser, F. C. Visser, and A. A. Lammertsma
Image-Derived Input Functions for Determination of MRGlu in Cardiac 18F-FDG PET Scans
J. Nucl. Med., November 1, 2001; 42(11): 1622 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B.L Gerber, F.F Ordoubadi, W Wijns, J.-L.J Vanoverschelde, M.J Knuuti, M Janier, P Melon, P.K Blanksma, A Bol, J.J Bax, et al.
Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of18F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability
Eur. Heart J., September 2, 2001; 22(18): 1691 - 1701.
[Abstract] [PDF]


Home page
CirculationHome page
J. vom Dahl, O. Muzik, E. R. Wolfe Jr, C. Allman, G. Hutchins, and M. Schwaiger
Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability
Circulation, January 15, 1996; 93(2): 238 - 245.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
J. Th. Locher, L. D. Frey, K. Seybold, and H. Jenzer
Myocardial 18F-FDG-PET: Experiences with the Euglycemic Hyperinsulinemic Clamp Technique
Angiology, April 1, 1995; 46(4): 313 - 320.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D. J. Betteridge, E. Ferrannini, and P. G. Camici
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1163 - E1171.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement